HOME >> BIOLOGY >> NEWS
Carnegie Mellon researcher proposes development of artificial cells to fight disease

PITTSBURGHCarnegie Mellon University's Philip LeDuc predicts the use of artificially created cells could be a potential new therapeutic approach for treating diseases in an ever-changing world. LeDuc, an assistant professor of mechanical and biomedical engineering, penned an article for the January edition of Nature Nanotechnology Journal about the efficacy of using man-made cells to treat diseases without injecting drugs.

This idea was developed by a team of researchers from disciplines including biology, chemistry and engineering during an exciting conference organized by the National Academies and the Keck Foundation for developing new disease-fighting approaches for the future.

"Our proposal is to use naturally available molecules to create pseudo-cell factories where we create a super artificial cell capable of targeting and treating whatever is ailing the body. The human cell is like a bustling metropolis, and we aim to tap the energy and diversity of the processes in a human cell to help the body essentially heal itself," LeDuc said.

Because the cell is an amazingly efficient system already, LeDuc and his team of researchers plan to use its microscopic package of tightly organized parts to improve medical treatment in diseases that exist in the body. According to LeDuc's journal article, the living cell operates much like a tiny industrial complex. His article proposes using the processes in a cell, such as the membrane, to create an enclosed functioning environment for a nanofactory. Then, by using other biologically inspired processes like molecular-binding and transport, the pseudo-cell can target, modify and deliver chemicals that the body needs to function properly.

In contrast to traditional drug-discovery ideas, where the product is delivered many times into the body, this journal article suggests using molecules that are already in the body and modifying these nanoscale systems to produce the biochemicals deficient
'"/>

Contact: Chriss Swaney
swaney@andrew.cmu.edu
412-268-5776
Carnegie Mellon University
7-Feb-2007


Page: 1 2

Related biology news :

1. Carnegie Mellons Peter Adams receives EPA research grant
2. Carnegie Mellon scientists find key HIV protein makes cell membranes bend more easily
3. Carnegie Mellons David Sholl identifies new materials
4. Carnegie Mellon University scientists identify genes activated during learning and memory
5. Carnegie Mellon University research shows how sensory-deprived brain compensates
6. Carnegie Mellon researchers urge regulators to rethink strategies for soot emission
7. Carnegie Mellon engineers devise new process to improve energy efficiency of ethanol production
8. DNA gets new twist: Carnegie Mellon scientists develop unique DNA nanotags
9. Carnegie Mellons Granger Morgan pens op-ed
10. Carnegie Mellon scientist plays key role in unveiling sea urchin genome
11. Carnegie Mellon study reveals that odor discrimination is linked to the timing at which neurons fire

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the ... million people each year. Especially those living in larger cities are affected by air ... one of the most pollution-affected countries globally - decided to take action. , “I ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology:
Cached News: